Nowadays a lot of new active substances as anticancer cervix agents have been developed. One of the protein targets in discovery of anticancer cervix drugs is Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK). In this present research the Quantitative Structure and Activity Relationship (QSAR) of quinazoline derivatives as inhibitors of EGFR-TK has been studied. Physicochemical parameters of quinazoline derivatives were calculated predictors to obtain the QSAR equation, and was then applied to predict the activity of new quinazoline derivatives. The best QSAR equation is IC 50-pred = -(3.155±19.369)*glob + (2.280±1.291)*mr -(0.136±0.103)*TPSA -(1.599±2.585)*Log P -0.186±8.861, with n = 13, r = 0.896, r 2 = 0.803, F cal = 8.152, F = 2.123, SE =1.685, Sig = 0.006, q 2 = 0.354. Based on the QSAR equation and by using the Topliss Scheme approach, three new quinazoline derivative showed higher inhibition activity than that of parent compound, and molecular docking study has shown the interaction between the those new ligand with active site of EGFR-TK.
Introduction
Cancer has caused high mortality in the world. Every year, 14.1 million have been indicated as cancer patients, and 8.2 million are died due to the cancer disease [1] . The main procedure in cancer treatment is surgery, irradiation and chemotherapy. Although chemotherapy can induce secondary primer cancer, it has advantage compare to that of surgery or radiation because of its ability to treat metastasis cancer, whereas surgery and radiation therapy is limited to certain areas [2] .
Effort to discover new safe anticancer drugs, either natural or synthetic has been a big challenge for pharma companies as well as dedicated research center. In the past, drug discovery are based on trial and error so it was very expensive and took a long time to launch new chemical entity. Today, with the help of computer hardware and software, the process of discovery of new active substances is more effective in cost and time.
Quantitative Structure and Activity Relationship (QSAR) study is one approach in an effort to design and discover new active substances better than previous compounds by using computer program (in silico). In the present work, QSAR studies were performed using a data set of quinazoline derivatives synthesized by ElAzab et al [2] . Twenty-seven compounds of quinazoline derivatives were tested their antitumor activity against HeLa cells. The activity mechanism of these ligand series is by inhibiting Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) _____________________________ * Corresponding author: La Ode Aman, E-mail: laode_aman@ung.ac.id through ATP binding pocket in the N-terminal domain mediated by water hydrogen bonds
Experimental
Data set Twenty-seven of quinazoline derivatives with anticancer activity as synthesized and tested by ElAzab et al [2] were used as data set. The molecule structure and their activity are listed in Table 1 .
Calculation parameters
Molecular structure was modeled by HyperChem ® Release 8.0. All structure optimized by semi empirical AM1 method with gradient of 0.01 kcal/Å. All descriptors were calculated using MOE 2007.09 the QSAR study. Those descriptors are partition coefficient (log P), solubility (log S), total energy (Etot ), electronics energy (E-ele ), HOMO energy (E-HOMO ), LUMO energy (E-LUMO ), total dipole moment (μ) , heat formation (HF), Van der Waals volume (Vw), globularity (GLOB), molar refractivity (mr), hydrophobic surface area (A) and total atomic polarizability. ) is an indicator of performance and stability model [3] which is calculated according to the following formula:
Statistical analysis
where, y i = experimental activity, ӯ i = average of experimental activity, and ŷ i = cross validation of predictive activity for compound i.
By applying LOO, a selected model was obtained.
The best QSAR equations have statistical criteria of r 2 ≥ 0.8, and q 2 ≥ 0.5. If the QSAR equations obtained does not fulfill these criteria, it means there is/are the outlier data which should be excluded
Design of new derivatives
There are three important measures in the design of new derivatives, namely (i) determining lead compound, (ii) selecting the substituents of lead compound which is replaced by a new substituent, and (iii) determine the list of new substituents. In this study, compound Q07 (Table 1) is a lead for designing new quinazoline derivatives. Substituents are selected for designing new compound using Topliss Scheme approach. It was obtained 10 new substituents as follow: -H, -CH 3 , -OCH 3 , -CF 3 , -NH 2 , -OH, -OC 6 H 5 , -NO 2 , -CN, -COCH 3 . Modification was conducted on Cl position so that obtained 10 new quinazoline derivatives.
Molecular docking
The study of ligands-EGFR-TK interaction was performed by using molecular docking techniques on Arguslab 4.0.1. There are two parameters which were observed in the molecular docking i.e. ΔG (free energy change) and hydrogen bonds formed between the ligand and the receptor (number of hydrogen bond and distance).
Results and Discussion
Statistical analysis was applied using multilinear regression with combination 2, 3, and 4 parameters as dependent variables and anticancer activity as independent variable. Statistical quality parameter using correlation coefficient (r), the square of the correlation coefficient (r Thus, it showed that the four physicochemical properties of quinazoline derivatives which involved in acting as inhibitor of the EGFR-TK were topology of polar surface area, partition coefficient, globularity, and molar refractivity.
Design of new derivatives
The best QSAR equation was used as a basis for predicting activity of new quinazoline derivative which were estimated to have anticancer activity. The new quinazoline derivatives were obtained by substitution of Cl group in the lead compound with a groups of H, CH 3 , OCH 3 , CF 3 , NH 2 , OH, OC 2 H 5 , NO 2 , CN, and COCH 3 , thus afforded ten new quinazoline derivatives. Using parameters of mr, TPSA, glob and log P as described in QSAR equation (Eq. 2), it will then be obtained theoretical or predictive anticancer activity (IC 50 pred.) of each new derivative as shown in Table 2 . Table 2 shows there are three derivatives which have better activity than that of lead compound (IC 50 = 3.56). They are QD05, QD06 and QD09.
The molecular structure and anticancer activity of those compounds and their theoretically activity are shown in Fig. 1 , 2 and 3. Molecular docking aims to study the interaction of ligands with receptor. Three new compounds quinazoline derivative (QD05, QD06, and QD09) are studied the interaction between ligand and with EGFR-TK protein. By using software ArgusLab molecular docking results obtained are summarized in Figure 4 and Table 3 show interaction between QD09 and binding site of EGFR-TK. in which ΔG is a parameter related to the reactivity of a compound with a receptor. According to Sellasie [4] , the spontaneity of the reaction between the compounds with receptor occurs with a decrease in free energy. It means that the more negative of free energy of a compound, the higher the spontaneity of the reaction between compounds with the receptor. Table 3 shows that all three new derivatives have a marked negative (-) ΔG. Thus, these ligands have the ability to bind to the EGFR-TK binding site.
Conclusion
The best QSAR equation for quinazoline derivatives as inhibitor of EGFR-TK is IC 50 -pred = (-3.155 ±19.369)*glob + (2.280±1.291)*mr -(0.136±0.103)*TPSA -(1.599±2.585)*Log P -0.186±8.861, with n = 13, r = 0.896, r 2 = 0.803, F cal = 8.152, F= 2.123, SE = 1.6859896, Sig = 0.006, q 2 = 0.354093. Three new quinazoline derivatives are predicted to have anticancer cervix activity through inhibition of EGFR-TK. 
